Inhibitor of growth (ING) family: An emerging molecular target for cancer therapy

Journal of Hard Tissue Biology

Volumn 17, Issue 1, 2008, Pages 1-10

  Gunduz, Esra ^a,b   Gunduz, Mehmet ^a,b   Beder, Levent Bekir ^c   Tamamura, Ryo ^a   Nagatsuka, Hitoshi ^a   Nagai, Noriyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer; Head and neck cancer; ING family; ING1; Tumor suppressor gene

Indexed keywords

EID: 70349915938     PISSN: 13417649     EISSN: None     Source Type: Journal    
DOI: 10.2485/jhtb.17.1     Document Type: Review

References (68)

1. Hinds PW and Weinberg RA. Tumor suppressor genes. Curr Opin Genet Dev 4: 135-141,1994
2. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823,191
3. 3. Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ and Wakefield LM. Transforming growth factor-b1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 4: 802-807,1998 (Pubitemid 28331021)
4. 4. Bai F, Pei XH, Godfrey VL and Xiong Y. Haploinsufficiency of p18 (INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol 23: 1269-1277,2003 (Pubitemid 36177036)
5. Russell M, Berardi P, Gong W and Riabowol K. Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Exp Cell Res 312: 951-961,2006
6. 6. Noutnan GS, Anderson JJ, Lunec J and Angus B. The role of the tumour suppressor p33 ING1b in human neoplasia. J Clin Pathol 56: 491-496, 2003 (Pubitemid 36819419)
7. 7. Garkavtsev I, Kazarov A, Gudkov A and Riabowol K. Suppression of the novel growth inhibitor p33INGl promotes neoplastic transformation. Nat Genet 14: 415-420, 1996 (Pubitemid 26414585)
8. 8. Helbing CC, Veilette C, Riabowol K, Johnston RN and Garkavtsev I. A novel candidate tumor suppressor gene, ING1, is involved in the regulation of apoptosis. Cancer Res 57: 1255-1258, 1997 (Pubitemid 27152547)
9. 9. Zeremski M, Horrigan SK, Grigorian IA, Westbrook CA and Gudkov AV. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34. Somatic Cell Mol Genet 23: 233-236, 1997 (Pubitemid 27444329)
10. 10. Feng X, Hara Y and Riabowol K. Different HATS of the INGl gene family. Trends Cell Biol 12: 532-538,2002 (Pubitemid 35346704)
11. Aasland R, Gibson TJ and Stewart AF. The PHD finger: implications for chrornatm-mediated transcriptional regulation. Trends Biochem Sci 20: 56-59,1995
12. 12. Zeremski M, Hill JE, Kwek SS, Grigorian IA, Gurova KV, Garkavtsev IV, Diatchenko L, Koonin EV and Gudkov AV. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem 274: 32172-32181, 1999 (Pubitemid 129503814)
13. 13. Ha S, Park S, Yun CH and Choi Y. Characterization of nuclear localization signal in mouse INGl homolog protein. Biochem Biophys Res Commun 293: 163-166, 2002 (Pubitemid 34694186)
14. 14. Ragvin A, Valvatne H, Erdal S, Arskog V, Tufteland KR, Breen K, Oyan AM, Eberharter A, Gibson TJ, Becker P and Aasland R. Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300. J Mol Biol 337: 773-788, 2004 (Pubitemid 38368924)
15. 15. Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris C and Riabowol K. ING1 represses transcription by direct DNA binding and through effects onp53, Cancer Res 63: 5785-5792, 2003 (Pubitemid 37187475)
16. 16. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K and Shimizu K. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 60: 3143-3146, 2000 (Pubitemid 30407907)
17. 17. Scott M, Bonnefm P, Vieyra D, Boisvert FM, Young D, Bazett-Jones DP and Riabowol K. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J Cell Sci 114, 3455-3462, 2001 (Pubitemid 33019762)
18. Berardi P, Russell M, El-Osta A and Riabowol K. Functional links between transcription, DNA repair and apoptosis. Cell Mol Life Sci 61: 2173-2180, 2004
19. 19. Shimada Y, Saito A, Suzuki M, Takahashi E and Horie M. Cloning of a novel gene (INGL) homologous to ING1, a candidate tumor suppressor. Cytogenet Cell Genet 83: 232235, 1998 (Pubitemid 29112747)
20. 20. Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K and Harris CC. DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci USA 98: 9671-9676, 2001 (Pubitemid 32769361)
21. 21. Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N1 Nishizaki K and Shimizu K. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21: 4462-4470,2002 (Pubitemid 34774848)
22. 22. Gozani O, Karuman P, Jones DR, Ivanov D, Cha J Lugovskoy AA, Baird CL, Zhu H, Field SJ, Lessnick SL, Villasenor J, Mehrotra B, Chen J, Rao VR, Brugge JS, Ferguson CG, Payrastre B, Myszka DG, Cantley LC, Wagner G, Divecha N, Prestwich GD, Yuan J. The PHD finger of the cromatinassociated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114: 99-111,2003 (Pubitemid 36859844)
23. 23. Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC. p29ING4 and p28ING5 bind to p53 andp300, and enhance p53 activity. Cancer Res 63: 2373-2378, 2003 (Pubitemid 36605171)
24. 24. Gunduz M, Nagatsuka H, Demircan K, Gunduz E, Cengiz B, Ouchida M, Tsujigiwa, H, Yamachika E, Fukushima K, Beder L, Hirohata S, Ninomiya Y, Nishizaki K, Shimizu K and Nagai N. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356: 109-117,2005 (Pubitemid 41175976)
25. 25. Unoki M, Shen JC, Zheng ZM and Harris CC. Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J Biol Chem 281: 34677-34686, 2006 (Pubitemid 46036673)
26. Raho G, Miranda C, Tamborini E, Pierotti MA and Greco A. Detection of novel mRNA splice variants of human ING4 tumor suppressor gene. Oncogene 26: 5247-5257, 2007
27. Vieyra D, Loewith R, Scott M, Bonnefin P, Boisvert FM, Cheema P, Pastyryeva S, Meijer M, Johnston RN, BazettJones DP, McMahon S, Cole MD, Young D and Riabowol K. Human ING1 proteins differentially regulate histone acetylation. J Biol Chem 277: 29832-29839,2002
28. 28. Kuzmichev A, Zhang Y, Erdjument-Bromage H, Tempst P, Reinberg D, Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33 (ING1). Mol Cell Biol 22: 835-848, 2002 (Pubitemid 34053062)
29. 29. Skowyra D, Zeremski M, Neznanov N, Li M, Choi Y, Uesugi M, Hauser CA, Gu W, Gudkov AV and Qin J. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDACl transcriptional corepressor complex, J Biol Chem 276: 8734-8739, 2001 (Pubitemid 37385441)
30. 30. Campos EI, Chin MY, Kuo WH, Li G. Biological functions of the ING family tumor suppressors. Cell Mol Life Sci 61: 2597-2613, 2004 (Pubitemid 39586520)
31. 31. Garate M, Campos EI, Bush JA, Xiao H and Li G. Phosphorylation of the tumor suppressor p33 (ING1b) at Ser126 influences its protein stability and proliferation of melanoma cells. FASEB J 21: 3705-3716, 2007 (Pubitemid 350075158)
32. 32. Tallen UG, Truss M, Kunitz F, Wellmann S, Unryn B, Sinn B, Lass U, Krabbe S, Holtkamp N, Hagemeier C, Wurm R, Henze G, Riabowol KT and von Deimling A. Downregulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. J Neurooncol 86: 23-30,2008 (Pubitemid 350263429)
33. 33. Coles AH, Liang H, Zhu Z, Marfella CG, Kang J, Imbalzano AN and Jones SN. Deletion of p37Ing1 in mice reveals a p53-independent role for Ingl in the suppression of cell proliferation, apoptosis, and tumorigenesis. Cancer Res 67: 2054-2061, 2007 (Pubitemid 46424223)
34. 34. Doyon Y, Cayrou C, Ullah M, Landry AJ, Cote V, Selleck W, Lane WS, Tan S, Yang XJ and Cote J. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 21:51-64,2006 (Pubitemid 43017848)
35. 35. Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pena P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, Cote J, Chua KF and Gozani O. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442: 96-99,2006 (Pubitemid 44064216)
36. 36. Pena PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O, Zhao R, Kutateladze TG. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442: 100-103, 2006 (Pubitemid 44064217)
37. 37. Feng X, Bonni S and Riabowol K. HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis. Mol Cell Biol 26: 9244-9255, 2006 (Pubitemid 44904420)
38. Doyon Y, Selleck W, Lane WS, Tan S and Cote J. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 24: 1884-1896, 2004
39. 39. Wang Y and Li G. ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells. J Biol Chem 281: 11887-11893,2006 (Pubitemid 43855450)
40. 40. Palacios A, Garcia P, Padro D, Lopez-Hernandez E, Martin I and Blanco FJ. Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4. FEBS Lett 580: 6903-6908, 2006 (Pubitemid 44909131)
41. 41. Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S and Riabowol K. Suppression of ING1 expression in sporadic breast cancer. Oncogene 18: 5187-5193,1999 (Pubitemid 29460654)
42. 42. Chen L, Matsubara N, Yoshino T, Nagasaka T, Hoshizima N, Shirakawa Y, Naomoto Y, Isozaki H, Riabowol K and Tanaka N. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res 61: 4345-4349, 2001 (Pubitemid 32685757)
43. Campos EI, Martinka M, Mitchell DL, Dai DL and Li G. Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair. Int J Oncol 25: 73-80,2004
44. 44. Hara Y, Zheng Z, Evans SC, Malatjalian D, Riddell DC, Guernsey DL, Wang LD, Riabowol K and Casson AG. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. Cancer Lett 192: 109-116,2003 (Pubitemid 36287666)
45. 45. Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M and Yokomise H. Reduced INGIb gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Clin Cancer Res 9: 4926-4934,2003 (Pubitemid 37323299)
46. 46. Yu GZ, Zhu MH, Zhu Z, Ni CR, Zheng JM and Li FM. Genetic alterations and reduced expression of tumor suppressor p33 (INGIb) in human exocrine pancreatic carcinoma. World J Gastroenterol 10: 3597-3601,2004 (Pubitemid 39619275)
47. ING1 and the relationship with p53 expression in human gastric cancer. Cancer Lett 147: 157-162, 1999
48. Zhu Z, Lin J, Qu JH, Feitelson MA, Ni CR, Li FM and Zhu MH. Inhibitory effect of tumor suppressor p33 (ING1b) and its synergy with p53 gene in hepatocellular carcinoma. World J Gastroenterol 11: 1903-1909, 2005
49. Vieyra D, Senger DL, Toyama T, Muzik H, Brasher PM, Johnston RN, Riabowol K and Forsyth PA. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Clin Cancer Res 9:5952-5961, 2004
50. 50. Lynas C and Bromidge T. Relative levels of alternative transcripts of the INGl gene and lack of mutations of p33/ ING1 in haematological malignancies. Leuk Res 26: 631-635, 2002 (Pubitemid 34465700)
51. 51. Krishnarnurthy J, Kannan K, Feng J, Mohanprasad BKC, Tsuchida N and Shanmugam G. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Oral Oncol 37: 222-224,2001 (Pubitemid 32245845)
52. 52. Tallen G, Kaiser I, Krabbe S, Lass U, Hartmann C, Henze G, Riabowol K and von Deimling A. No ING1 mutations in human brain tumours but reduced expreesion in high malignancy grades of astrocytoma. Int J Cancer 109: 476-479, 2004 (Pubitemid 38252781)
53. 53. Ohmori M, Nagai M, Tasaka T, Koeffier HP, Riabowol K and Takahara J. Decreased expression of p33ING1 mRNA in lymphoid malignancies. Am J Hematol 62:118-119, 1999 (Pubitemid 29463726)
54. 54. Tokunaga E, Maehara Y, Oki E, Kitamura K, Kakeji Y, Ohno S and Sugimachi K. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett 152: 15-22, 2000 (Pubitemid 30169013)
55. 55. Nouman GS, Anderson JJ, Crosier S, Shrimankar J, Lunec J and Angus B. Downregulation of nuclear expression of the p33 (ING1b) inhibitor growth protein in invasive carcinoma of the breast. J Clin Pathol 56: 507-511, 2003 (Pubitemid 36819421)
56. 56. Nouman GS, Anderson JJ, Wood KM, Lunec J, Hall AG, Reid MM and Angus B. Loss of nuclear expression of the p33 (ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia. J Clin Pathol 55: 596-601,2002 (Pubitemid 34888303)
57. 57. Nouman GS, Anderson JJ, Mathers ME, Leonard N, Crosier S, Lunec J and Angus B. Nuclear to cytoplasmic compartment shift of the p33ING1b tumor suppressor protein is associated with malignancy in melanocyte lesion. Histopathology 40: 360-366, 2002 (Pubitemid 34595587)
58. 58. Fabbro M and Henderson BR. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 282: 59-69, 2003 (Pubitemid 36259901)
59. Zhang HK, Pan K, Wang H, Weng DS, Song HF, Zhou J, Huang W, Li JJ, Chen MS and Xia JC. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett 261:183-192,2008
60. 60. Gunduz M, Beder LB, Gunduz E, Nagatsuka H, Fukushima K, Pehlivan D, Cetin E, Yamanaka N, Nishizaki K, Shimizu K and Nagai N. Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer. Cancer Sei 99:531-538,2008 (Pubitemid 351228570)
61. Wang Y, Dai DL, Martinka M and Li G Prognostic significance of nuclear 1NG3 expression in human cutaneous melanoma. Clin Cancer Res 13: 4111-4116, 2007
62. 62. Garkavtsev I, Kozin SV, Chemova O, Xu L, Winkler F, Brown E, Barnett GH and Jain RK. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428: 328-332, 2004 (Pubitemid 38418804)
63. 63. Kim S, Chin K, Gray JW and Bishop JM. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 101: 16251-16256, 2004 (Pubitemid 39552831)
64. 64. Cengiz B, Gunduz M, Nagatsuka H, Beder L, Gunduz E, Tamamura R, Mahmut N, Fukushima K, Ali MA, Naomoto Y, Shimizu K and Nagai N. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer. Oral Oncol 43: 241-247,2007 (Pubitemid 46228008)
65. Gunduz M. Functions of the tumor suppressor ING family genes. J Oral Biosci 47: 211-220,2005
66. 66. Scott M, Boisvert FM, Vieyra D, Johnston RN, Bazett-Jones DP and Riabowol K. UV induces nucleolar translocation of INGl through two distinct nucleolar targeting sequences. Nucleic Acids Res 29: 2052-2058, 2001 (Pubitemid 32472075)
67. Kim S. HuntING4 new tumor suppressors. Cell Cycle 4:516-517,2005
68. Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D, Mancini C, Lazzaretti M, Mazzera L, Ravanetti L, Bonomini S, Ferrari L, Miranda C, Ladetto M, Neri TM, Neri A, Greco A, Mangoni M, Bonati A, Rizzoli V and Giuliani N. The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-Ia activity being involved in myeloma-induced angiogenesis. Blood 110:4464-4475,2007